M518101 phase 2b study in plaque psoriasis patients - comparison study 3 -

Authors
Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2013
INTERVENTION: Intervention name : M518101 Dosage And administration of the intervention : Proper quantity twice a day Control intervention name : placebo Dosage And administration of the control intervention : Proper quantity twice a day Control intervention name : maxacalcitol ointment Dosage And administration of the control intervention : Proper quantity twice a day CONDITION: Plaque psoriasis PRIMARY OUTCOME: severity of plaque psoriasis INCLUSION CRITERIA: Patients diagnosed with plaque psoriasis. Outpatient.
Epistemonikos ID: 402caaccb45a9082973050f140e3ca1fe6c468ca
First added on: Aug 22, 2024